Evaluation of Paliperidone Palmitate Long-Acting Injectable Therapy by Duration of Illness in Patients With Schizophrenia

被引：0
|
作者：
Brown, Brianne [1 ]
Turkoz, Ibrahim [2 ]
Mancevski, Branislav [3 ]
Mathews, Maju [4 ]
机构：
[1] Janssen Sci Affairs LLC, Sci Affairs, Titusville, NJ USA
[2] Janssen Res & Dev LLC, Biostat, Titusville, NJ USA
[3] Janssen Sci Affairs LLC, Clin Dev, Titusville, NJ USA
[4] Janssen Res & Dev LLC, Global Med Affairs, Titusville, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2016年 / 79卷 / 09期
关键词：
Long-acting injectable; Paliperidone palmitate; Duration of illness;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
607
引用
收藏
页码：212S / 212S
页数：1
相关论文
共 50 条
  • [21] Angioedema Associated With Long-Acting Injectable Paliperidone Palmitate: A Case Report
    Papadopoulou, Athanasia
    Gkikas, Kitsos
    Efstathiou, Vasiliki
    Gkikas, Ilias
    Kokoris, Styliani
    Lagari, Vasiliki
    Papageorgiou, Charalabos
    Douzenis, Athanasios
    Siafakas, Nikolaos
    Rizos, Emmanouil N.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (06) : 730 - 732
  • [22] A case of tardive dystonia associated with long-acting injectable paliperidone palmitate
    Ma, Chia-Hao
    Chien, Yi-Ling
    Liu, Chen-Chung
    Chen, I-Ming
    Lin, Chia-Hsien
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (07) : 1251 - 1252
  • [23] Use of paliperidone palmitate long-acting injectable in a patient with a personality disorder
    Martinez, N.
    Benitez Cerezo, E.
    Garcia Marin, S.
    EUROPEAN PSYCHIATRY, 2017, 41 : S714 - S714
  • [24] Onset of Efficacy of Long-acting Injectable Paliperidone Palmitate for Negative Symptoms and Anxiety/Depression in Subjects With Schizophrenia
    Fu, Dong-Jing
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Ma, Yi-Wen
    Alphs, Larry
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S511 - S512
  • [25] PALIPERIDONE PALMITATE: PLACE IN THERAPY AND PRACTICAL USAGE GUIDELINES FOR A NEW LONG-ACTING INJECTABLE ANTIPSYCHOTIC
    Newton, Richard
    Damodaran, Saji
    Hustig, Harry
    Lakshmana, Raju
    Lee, Joseph
    Motamarri, Balaji
    Norrie, Peter
    Parker, Robert
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 : A46 - A46
  • [26] COST EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS RISPERIDONE LONG-ACTING INJECTABLE, QUETIAPINE AND OLANZAPINE FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA IN COLOMBIA
    Casallas, C.
    Ariza, J. G.
    VALUE IN HEALTH, 2013, 16 (07) : A695 - A695
  • [27] Paliperidone palmitate long-acting injection in schizophrenic patients
    Suarez Gisbert, E.
    EUROPEAN PSYCHIATRY, 2020, 63 : S540 - S540
  • [28] A comparative randomized, open-label, rater-blinded study of paliperidone palmitate and risperidone long-acting injectable therapy in patients with schizophrenia
    Li, H.
    Rui, Q.
    Ning, X.
    Xu, H.
    Gu, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 167 - 167
  • [29] ECONOMIC ANALYSIS OF PALIPERIDONE LONG-ACTING ACTING INJECTABLE FOR CHRONIC SCHIZOPHRENIA IN PORTUGAL
    Maia-Lopes, S.
    Van Impe, K.
    Goswami, P.
    Einarson, T. R.
    VALUE IN HEALTH, 2015, 18 (07) : A410 - A410
  • [30] Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
    Patel, R.
    Chesney, E.
    Taylor, M.
    Taylor, D.
    McGuire, P.
    PSYCHOLOGICAL MEDICINE, 2018, 48 (10) : 1616 - 1623
12345